An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation

European Heart Journal

Volumn 23, Issue 11, 2002, Pages 892-900

  Brignole, Michele ^a   Menozzi, C ^b   Gasparini, M ^c   Bongiorni, M G ^d   Botto, G L ^e   Ometto, R ^f   Alboni, P ^g   Bruna, C ^h   Vincenti, A ⁱ   Verlato, R ^j  

^a OSPEDALI RIUNITI   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d CISANELLO HOSPITAL   (Italy)

^e SANT ANNA HOSPITAL   (Italy)

^f SAN BORTOLO HOSPITAL   (Italy)

^g Ospedale Civile   (Italy)

^h S CROCE E CARLE HOSPITAL   (Italy)

ⁱ SAN GERARDO HOSPITAL   (Italy)

^j Ospedale Civile P Cosma   (Italy)

more..

Author keywords

Antiarrhythmia agents; Atrial fibrillation; Atrioventricular node; Catheter ablation; Pacemakers

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLECAINIDE; PROPAFENONE; SOTALOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PACING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CATHETER ABLATION; ECHOCARDIOGRAPHY; FEMALE; FLECAINIDE; FOLLOW-UP STUDIES; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROPAFENONE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SOTALOL; TIME FACTORS;

EID: 0036297481     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2971     Document Type: Article

References (17)

1. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias
2. An assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. A randomized controlled study
3. Patients' self-assessment of their congestive heart failure. Part II: Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire
4. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance
5. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation. A randomized controlled study
6. Management of patients with atrial fibrillation. A statement for healthcare professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
7. Rhythm or rate control in atrial fibrillation. Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomized trial
8. Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation
9. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction. A retrospective analysis of the SOLVD Trials
10. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: A prospective study in 344 patients with baseline sinus rhythm
11. Therapy of atrial fibrillation: Rhythm control versus rate control
12. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation
13. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT studies
14. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation. Effects of pacing mode and mode-switch algorithm
15. Thromboembolism after atrioventricular node ablation and pacing: Long-term follow-up
16. Clinical outcomes after ablation and pacing therapy for atrial fibrillation
17. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation